Access EIS investments for August 2022

Syndicate Room

6 September 2022•2 min read

In August, SyndicateRoom added four new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page). Find out more about our fund, Access EIS, or read about our new portfolio companies below.

Wild Hydrogen

Our angel partner in the round has a weighted IRR of 32% and has invested in Acacia Pharma, Arecor and Stemnovate.

Total Round: approx. £1,000,000.

Visit website

Syndi

Our angel partner in the round has a weighted IRR of 90% and has invested in Nutmeg, Purple Bricks, and Second Home, among others.

Total Round: approx. £440,000.

Stage: Post-revenue.

Visit website

Herd

Our angel partner in the round has a flat CAGR of 32% and has invested in Chosen AI, WiseAlpha and Credit Kudos.

Total Round: approx. £490,000.

Visit website

Presto

Our angel partner in the round has a flat CAGR of 36% and has invested in Class4Kids, Patch and WeGift.

Total Round: approx. £460,000.

Stage: Post-revenue.

Visit website

Risk warning: Please click here to read the full risk warning.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).

We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.